Precision Lung Cancer Survivorship Care Intervention

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorJerod L Stapleton, PhD

About this trial

The overarching goal of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program is to reduce the burden of lung cancer by offering an innovative survivorship care approach that improves lung cancer quality of life, overcomes lung cancer stigma, and helps survivors engage with care. The project involves a two-group parallel randomized clinical trial comparing the impact of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program (KLCLCSC) among lung cancer survivors (N=300) against an enhanced usual care condition (bibliotherapy+assessment) on quality of life outcomes.

Eligibility criteria

Qualifiers

Have been diagnosed with lung cancer

Reside in a rural county as determined by a Rural Urban Continuum Code (RUC) of 4 or higher

Be at least 18 years of age or older

Be able to communicate effectively in English

Disqualifiers

Have significant psychiatric disturbance that requires a higher level of care

Have substance abuse/dependence that requires a higher level of care

Are participating in another lung cancer survivorship care intervention

Have previously participated in the Kentucky LEADS Lung Cancer Survivorship Care Program

Trial design

Treatments tested in this trial

  • Kentucky LEADS Collaborative Lung Cancer Survivorship Care Program
  • Enhanced Usual Care

Treatment groups

300 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Jerod L Stapleton, PhD

Lead sponsor

University of Kentucky

Sponsor institution

University of Louisville

Collaborator

G02 for Lung Cancer

Collaborator

National Cancer Institute (NCI)

Collaborator